209 related articles for article (PubMed ID: 19195683)
1. Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo.
Ekholm M; Kahan T; Jörneskog G; Bröijersen A; Wallén NH
Thromb Res; 2009 May; 124(1):110-5. PubMed ID: 19195683
[TBL] [Abstract][Full Text] [Related]
2. Altered vascular responses to circulating angiotensin II in familial combined hyperlipidemia.
Jörneskog G; Kahan T; Ekholm M; Bröijersén A; Wallén NH
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1037-44. PubMed ID: 18799967
[TBL] [Abstract][Full Text] [Related]
3. Infusion of angiotensin II increases fibrinolysis in healthy individuals but not in patients with familial combined hyperlipidemia.
Ekholm M; Kahan T; Jörneskog G; Bröijersén A; Wallén NH
Blood Coagul Fibrinolysis; 2016 Jan; 27(1):113-6. PubMed ID: 26340459
[TBL] [Abstract][Full Text] [Related]
4. Haemostatic and inflammatory alterations in familial hypercholesterolaemia, and the impact of angiotensin II infusion.
Ekholm M; Kahan T; Jörneskog G; Brinck J; Wallén NH
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):328-38. PubMed ID: 25908220
[TBL] [Abstract][Full Text] [Related]
5. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
[TBL] [Abstract][Full Text] [Related]
6. Changes in thrombin generation, fibrinolysis, platelet and endothelial cell activity, and inflammation following endovascular abdominal aortic aneurysm repair.
Abdelhamid MF; Davies RS; Adam DJ; Vohra RK; Bradbury AW
J Vasc Surg; 2012 Jan; 55(1):41-6. PubMed ID: 21975058
[TBL] [Abstract][Full Text] [Related]
7. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.
Raaphorst J; Johan Groeneveld AB; Bossink AW; Erik Hack C
Thromb Haemost; 2001 Aug; 86(2):543-9. PubMed ID: 11522001
[TBL] [Abstract][Full Text] [Related]
8. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.
Robinson SD; Dawson P; Ludlam CA; Boon NA; Newby DE
Clin Sci (Lond); 2006 Mar; 110(3):353-60. PubMed ID: 16309383
[TBL] [Abstract][Full Text] [Related]
9. The relationship among TAFI, t-PA, PAI-1 and F1 + 2 in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
Chudý P; Kotuličová D; Staško J; Kubisz P
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):493-8. PubMed ID: 21519232
[TBL] [Abstract][Full Text] [Related]
10. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
Kruithof EK; Mestries JC; Gascon MP; Ythier A
Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
[TBL] [Abstract][Full Text] [Related]
11. [Effects of angiotensin II on inflammation mediators in healthy subjects].
Lottermoser K; Ulrich-Merzenich G; Vetter H; Düsing R
Dtsch Med Wochenschr; 2003 Nov; 128(47):2470-5. PubMed ID: 14628252
[TBL] [Abstract][Full Text] [Related]
12. Intra-arterial tumor necrosis factor-alpha impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans.
Chia S; Qadan M; Newton R; Ludlam CA; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):695-701. PubMed ID: 12692009
[TBL] [Abstract][Full Text] [Related]
13. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
14. Systemic coagulation and fibrinolysis in patients with or at risk for the adult respiratory distress syndrome.
Groeneveld AB; Kindt I; Raijmakers PG; Hack CE; Thijs LG
Thromb Haemost; 1997 Dec; 78(6):1444-9. PubMed ID: 9423792
[TBL] [Abstract][Full Text] [Related]
15. Effects of the mineralocorticoid fludrocortisone on fibrinolytic function in healthy subjects.
Lottermoser K; Hertfelder HJ; Wehling M; Schiermeyer B; Vetter H; Düsing R
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):357-60. PubMed ID: 11967823
[TBL] [Abstract][Full Text] [Related]
16. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function.
Ridker PM; Gaboury CL; Conlin PR; Seely EW; Williams GH; Vaughan DE
Circulation; 1993 Jun; 87(6):1969-73. PubMed ID: 8504511
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
[TBL] [Abstract][Full Text] [Related]
19. Dyslipidemias and fibrinolysis.
Puccetti L; Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Auteri A
Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815
[TBL] [Abstract][Full Text] [Related]
20. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]